Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
170.37
-1.49 (-0.87%)
At close: Jun 23, 2025, 4:00 PM
171.00
+0.63 (0.37%)
After-hours: Jun 23, 2025, 6:59 PM EDT
Natera Employees
Natera had 4,434 employees as of December 31, 2024. The number of employees increased by 1,141 or 34.65% compared to the previous year.
Employees
4,434
Change (1Y)
1,141
Growth (1Y)
34.65%
Revenue / Employee
$412,945
Profits / Employee
-$42,797
Market Cap
23.26B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
Dec 31, 2023 | 3,293 | 275 | 9.11% |
Dec 31, 2022 | 3,018 | 348 | 13.03% |
Dec 31, 2021 | 2,670 | 855 | 47.11% |
Dec 31, 2020 | 1,815 | 776 | 74.69% |
Dec 31, 2019 | 1,039 | 64 | 6.56% |
Dec 31, 2018 | 975 | 82 | 9.18% |
Dec 31, 2017 | 893 | 41 | 4.81% |
Dec 31, 2016 | 852 | 136 | 18.99% |
Dec 31, 2015 | 716 | 42 | 6.23% |
Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NTRA News
- 19 days ago - Natera Announces Medicare Coverage for Signatera™ Genome - Business Wire
- 21 days ago - SignateraTM Genome Clinical Performance Highlighted at ASCO 2025 - Business Wire
- 4 weeks ago - Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Business Wire
- 5 weeks ago - Natera: The Clues In Q1 Earnings - Seeking Alpha
- 6 weeks ago - Natera, Inc. (NTRA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Natera Reports First Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress - Business Wire
- 6 weeks ago - Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows - Business Wire